Evidence map›Paper›PMID 32346524›Full record

ArticleAnnals of global health2020

Diabetic Microvascular Complications Among Children and Adolescents in Northwestern Tanzania: A Cross-Sectional Study.

Delfina Msanga, Karl Reis, Neema Kayange, Respicious Bakalemwa, Benson Kidenya, Duncan Hau, Christopher Mwanansao, Dina Mahamba, Sofia Ottaru, Elizabeth Kwiyolecha and 1 more

Open access · goldAbstract read
In one paragraph

Article in Annals of global health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 3 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 3 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Delfina MsangaWeill Bugando School of Medicine, Mwanza, TZ.
Karl ReisWeill Bugando School of Medicine, Mwanza, TZ.
Neema KayangeWeill Bugando School of Medicine, Mwanza, TZ.
Respicious BakalemwaWeill Bugando School of Medicine, Mwanza, TZ.
Benson KidenyaWeill Bugando School of Medicine, Mwanza, TZ.
Duncan HauCenter for Global Health, Division of Medicine, Weill Cornell Medical College, New York, NY, US.
Christopher MwanansaoWeill Bugando School of Medicine, Mwanza, TZ.
Dina MahambaWeill Bugando School of Medicine, Mwanza, TZ.
Sofia OttaruWeill Bugando School of Medicine, Mwanza, TZ.
Elizabeth KwiyolechaWeill Bugando School of Medicine, Mwanza, TZ.
Robert PeckWeill Bugando School of Medicine, Mwanza, TZ.
Bugando Medical Centre · TZCornell University · USCenter for Global Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Africa is experiencing a rapid increase in morbidity and mortality related to diabetes mellitus (DM). Contemporary data are needed to guide efforts to improve prevention and treatment for microvascular complications in children and adolescents in Africa. This study was conducted to assess prevalence of diabetic microvascular complications in northwestern Tanzania, including nephropathy, retinopathy, and neuropathy, as well as associated risk factors. Objectives: 1) To determine the prevalence of microvascular complications and the overlap of nephropathy, retinopathy and neuropathy and 2) to determine factors associated with the development of microvascular complications. Methods: This cross-sectional study included 155 children and adolescents with DM consecutively attending all three health centers providing diabetes care for children in the Mwanza region of Tanzania. Participants were examined for microvascular complications and possible risk factors. Results: Fifty-one of 155 participants (age: 5-19 years) had diabetic nephropathy (32.9%), 16 had diabetic retinopathy (10.3%), and 21 had diabetic neuropathy (13.6%). Risk factors for development of a microvascular complication included age, duration of DM, and poor glycemic control. Of the participants, 107 had poor levels of glycemic control (69%) with HbA1C levels >10%. Conclusion: The prevalence of microvascular complications, especially that of nephropathy, was disturbingly high. Risk factors for microvascular complications were similar to other studies from Africa and included poor glycemic control, older age, and longer duration of DM. Innovative, locally appropriate systems for optimizing glycemic control are urgently needed.

Indexed as

AdolescentAge FactorsChildChild, PreschoolDiabetes Mellitus, Type 1Diabetic NephropathiesDiabetic NeuropathiesDiabetic RetinopathyFemaleGlycated HemoglobinHumansHypoglycemic AgentsInsulinMalePrevalenceRisk FactorsGlycated Hemoglobinhemoglobin A1c protein, humanHypoglycemic AgentsInsulin

Identifiers

PMID32346524
PMCPMC7181947
OpenAlexW3018170204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.